These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3138818)

  • 21. Anti Rh 17 in a multigravida with Rh-D-/[symbol: see text] genotype resulting in haemolytic disease of the newborn.
    Davis SG; Aboud E
    Clin Exp Obstet Gynecol; 1998; 25(3):75. PubMed ID: 9856300
    [No Abstract]   [Full Text] [Related]  

  • 22. [Feto-maternal blood immunization. Physiopathology, diagnosis, treatment].
    Gaucherand P; Rudigoz RC
    Rev Prat; 1990 May; 40(14):1329-34. PubMed ID: 2113708
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn.
    Pollock JM; Bowman JM
    Vox Sang; 1990; 59(3):176-9. PubMed ID: 2124753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
    Liu KL; Li BJ; Peng JY
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
    [No Abstract]   [Full Text] [Related]  

  • 25. Rh hemolytic disease of the newborn treated with high-dose intravenous immunoglobulin and plasmapheresis.
    Besalduch J; Forteza A; Durán MA; Reyero J; Caso M
    Transfusion; 1991 May; 31(4):380-1. PubMed ID: 1902339
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anti-Rh immunoglobulin (D) subclasses and hemolytic disease of the newborn].
    Cregut R; Pinon F; Brossard Y
    Nouv Presse Med; 1973 Jul; 2(29):1947. PubMed ID: 4198948
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infection risk factors in newborn infants with fetal erythroblastosis].
    Maszkiewicz W; Ornat K; Laskowska B; Irzyńska D; Manerowska D
    Acta Haematol Pol; 1988; 19(3-4):230-8. PubMed ID: 3150899
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunization in pregnancy].
    Heier HE; Berge LN; Hervig T; Kiserud T; Børset M; Eik-Nes S; Arsenovic M; Acharya G
    Tidsskr Nor Laegeforen; 2009 Oct; 129(19):2016-8. PubMed ID: 19823209
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of C1q in Rhesus haemolytic disease of the newborn.
    Poorkhorsandi ME; Gupte SC
    Indian J Med Res; 1996 Sep; 104():208-12. PubMed ID: 8898479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric analyses of the subclasses of red cell IgG antibodies.
    Lynen R; Neuhaus R; Schwarz DW; Simson G; Riggert J; Mayr WR; Köhler M
    Vox Sang; 1995; 69(2):126-30. PubMed ID: 8585193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemoglobin level analysis in the pregnancy complicated by rhesus isoimmunization].
    Wiczyńska-Zajac A; Wielgoś M; Bomba-Opoń D; Marianowski L
    Ginekol Pol; 2000 Jun; 71(6):519-23. PubMed ID: 11002555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rhesus immunization in a rhesus-positive pregnant woman: fetal erythroblastosis caused by the rhesus antibody anti-C].
    Konstantin-Hansen KF; Larsen HL; Hejl M
    Ugeskr Laeger; 1989 Jun; 151(24):1553. PubMed ID: 2506685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serological conflict: relation between antibody titer, Liley's zone and the condition of the fetus and newborn infant].
    Czeszyńska M; Zieliński M; Czajkowski Z; Hnatyszyn G
    Acta Haematol Pol; 1991; 22(2):279-89. PubMed ID: 1841500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease.
    Berlin G; Selbing A; Gottvall T
    Prog Clin Biol Res; 1990; 337():337-40. PubMed ID: 2112753
    [No Abstract]   [Full Text] [Related]  

  • 36. [Determination of the degree of fetal injury by the Rh antibody titer in the amniotic fluid].
    Vitanova R
    Akush Ginekol (Sofiia); 1985; 24(1):43-7. PubMed ID: 3925801
    [No Abstract]   [Full Text] [Related]  

  • 37. IgG subclasses of anti-Rh antibodies in pregnant women.
    Frankowska K; Górska B
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1095-100. PubMed ID: 107909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new report of haemolytic disease of the newborn due to IgG anti-M (author's transl)].
    Martin Vega C; Ribera A; Gallart MT; Triginer J
    Sangre (Barc); 1980; 25(3):392-6. PubMed ID: 6968096
    [No Abstract]   [Full Text] [Related]  

  • 39. [Feto-maternal blood immunization. Screening, prevention].
    Mathieu FP; Gaillard G
    Rev Prat; 1996 Mar; 46(5):629-36. PubMed ID: 8815530
    [No Abstract]   [Full Text] [Related]  

  • 40. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.